abrdn Life Sciences Investors (HQL) vs Noah (NOAH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
abrdn Life Sciences Investors (HQL) has outperformed Noah (NOAH) over the past year, gaining 9.1% versus a loss of 36.1%. Over five years, HQL leads with a -15.6% price change compared with -79.1% for NOAH. On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 6.3x for Noah).
Noah offers the higher dividend yield (61.22% vs 10.96%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HQL | NOAH |
|---|---|---|
| Share price | $17.43 | $7.62 |
| Market cap | — | $523.08M |
| 1-day change | -0.74% | -1.42% |
| YTD return | +3.87% | -24.10% |
| 1-year return | +9.07% | -36.07% |
| 5-year return | -15.63% | -79.12% |
| P/E ratio (TTM) | 2.63 | 6.30 |
| Forward P/E | — | 5.24 |
| EPS (TTM) | $6.64 | $1.21 |
| Dividend yield | 10.96% | 61.22% |
| Annual dividend | $1.91 | $4.67 |
| 52-week high | $22.67 | $12.45 |
| 52-week low | $15.66 | $7.60 |
| Distance from 52-week high | -23.11% | -38.80% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +39.37% |
| Average volume | 146.74K | 105.05K |
| Shares outstanding | — | 68.65M |
| Employees | — | 1,582 |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HQL has outperformed NOAH by 45.1 percentage points over the past year.
- Noah trades at a higher earnings multiple (6.3x vs 2.6x trailing P/E).
- Noah offers a meaningfully higher dividend yield (61.22% vs 10.96%).
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
About Noah
NOAH stock →Noah Holdings Limited, together with its subsidiaries, operates as a wealth and asset management service provider with the focus on investment and asset allocation services for high net worth individuals and corporate entities in Mainland of China, Hong Kong, and internationally. It operates through Domestic Public Securities, Domestic Asset Management, Domestic Insurance, Overseas Wealth Management, Overseas Asset Management, and Overseas Insurance and Comprehensive Services segments.
Finance · Investment Managers · 1,582 employees
HQL vs NOAH FAQ
Which stock has performed better over the past year, HQL or NOAH?
HQL returned +9.07% over the past 12 months, compared with -36.07% for NOAH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, HQL or NOAH?
HQL has the lower trailing P/E at 2.6, versus 6.3 for NOAH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, abrdn Life Sciences Investors or Noah?
Noah has the higher yield at 61.22%, compared with 10.96% for abrdn Life Sciences Investors.
Are abrdn Life Sciences Investors and Noah in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.